ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2684

Multimodal Analysis Revealed Altered Brain Connectivity Patterns and Neuroinflammatory Processes in the Background of Difficult-To-Treat Rheumatoid Arthritis

Lilla Gunkl-Tóth1, Gergely Orsi2, Noémi Császár-Nagy3, Lili Duzsik4, Gábor Mátay4, Gábor Kumánovics5, Gábor Sütő2, Krisztina Csókási2, Szabolcs Takács6, Zoltán Vidnyánszky7, József Kun2, Krisztina Takács-Lovász2, Gellért Karvaly8, Róbert Farkas8, Anett Pintér8, Panna Királyhidi8, György Nagy8 and Zsuzsanna Helyes2, 1Semmelweis University, Budapest, Budapest, Hungary, 2University of Pécs, Pécs, Hungary, 3National University of Public Services, Budapests, Hungary, 4Psychosomatic Outpatient Clinic, Budapest, Hungary, 5University of Pecs, Pecs, Hungary, 6Károli Gáspár University, Budapest, Hungary, 7Brain Imaging Centre, Research Centre for Natural Sciences, Budapest, Hungary, 8Semmelweis University, Budapest, Hungary

Meeting: ACR Convergence 2025

Keywords: autoimmune diseases, Neuroimaging, pain, psychological status, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, October 29, 2025

Title: Abstracts: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes III: Long Live (Comorbidity and Outcomes) (2681–2686)

Session Type: Abstract Session

Session Time: 12:15PM-12:30PM

Background/Purpose: Despite advances in rheumatoid arthritis (RA) treatment, 5–20% of patients experience persistent symptoms, particularly pain, and are classified as difficult-to-treat (D2T). Factors such as treatment resistance, comorbidities, and central pain sensitization may contribute; however, the exact mechanisms remain unclear. This study focused on investigating the underlying factors of the D2T condition and revealing the connections between pain and inflammation with a multimodal approach.

Methods: 31 D2T RA (determined by the 2020 EULAR definition), 18 non-D2T RA patients, and 32 healthy controls (HCs) were included. All participants underwent a clinical assessment, psychological analysis (including in-depth interviews, the Rorschach test, and questionnaires), two resting-state functional MRI (fMRI) scans with standardized heat pain stimulation in between, as well as peripheral blood transcriptomic analysis and plasma metabolomics.

Results: Resting-state fMRI revealed significantly reduced intrinsic connectivity of the posterior cingulate cortex (PCC) in RA patients, especially in D2T RA. Following acute painful stimulation, intrinsic connectivity of the PCC increased in D2T RA, in contrast to the decreased connectivity observed in non-D2T RA patients and healthy controls (HCs). (Figure 1.) Seed-based analysis of the postcentral gyrus (PCG) revealed a reduction in connectivity strength across many connections within the somatosensory area, which were significantly altered after pain stimulation in all RA patients compared to HCs. Fractional amplitude of low-frequency fluctuations (fALFF) analysis revealed significantly reduced activity in several brain regions (e.g., lateral occipital cortex, middle frontal gyrus, medial prefrontal cortex, and frontal pole) in RA, with D2T patients showing the most significant reductions. Compared to non-D2T RA, D2T patients also exhibited lower fALFF in additional brain regions, indicating more complex alterations in pain and somatosensory processing, behavior, and cognitive functions, which aligns with our psychological results showing increased relational and decision-making inhibition, reduced motivation, and impaired mental control in RA. (Figure 2.) Transcriptomic analysis showed 70 downregulated and 17 upregulated differentially expressed (DE) mRNAs in D2T RA compared to the non-D2T RA group (e.g., neuregulin-1 (NRG1) or S100B). Functional analysis demonstrated a direct link of DE mRNAs to neuronal differentiation processes, neuroinflammation, or neuroplasticity. (Figure 3.) Metabolomic analysis revealed significant differences in amino acid and sphingolipid metabolism.

Conclusion: Teveal a novel neuroimmune signature of D2T RA, characterized by altered brain connectivity patterns, psychological disturbances, and distinct transcriptomic and metabolomic profiles. These results may lead to new opportunities for patient stratification, biomarker development, and personalized interventions targeting central mechanisms.Funding: HUN-REN–PTE Chronic Pain Research Group (14017), OTKA K138046 and K131479, TKP2021-EGA-29, National Brain Research Program, Richter Gedeon PhD Scholarship for LGT.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: L. Gunkl-Tóth: None; G. Orsi: None; N. Császár-Nagy: None; L. Duzsik: None; G. Mátay: None; G. Kumánovics: None; G. Sütő: None; K. Csókási: None; S. Takács: None; Z. Vidnyánszky: None; J. Kun: None; K. Takács-Lovász: None; G. Karvaly: None; R. Farkas: None; A. Pintér: None; P. Királyhidi: None; G. Nagy: None; Z. Helyes: None.

To cite this abstract in AMA style:

Gunkl-Tóth L, Orsi G, Császár-Nagy N, Duzsik L, Mátay G, Kumánovics G, Sütő G, Csókási K, Takács S, Vidnyánszky Z, Kun J, Takács-Lovász K, Karvaly G, Farkas R, Pintér A, Királyhidi P, Nagy G, Helyes Z. Multimodal Analysis Revealed Altered Brain Connectivity Patterns and Neuroinflammatory Processes in the Background of Difficult-To-Treat Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/multimodal-analysis-revealed-altered-brain-connectivity-patterns-and-neuroinflammatory-processes-in-the-background-of-difficult-to-treat-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/multimodal-analysis-revealed-altered-brain-connectivity-patterns-and-neuroinflammatory-processes-in-the-background-of-difficult-to-treat-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology